Answers are grounded in this paper and cite their sources.
AbstractClozapine is an effective but expensive antipsychotic agent. In this study, the rates and lengths of hospitalizations of a cohort of 75 inpatients with treatment-resistant psychotic disorders were examined for the 6-month period before starting clozapine and for up to five 6-month periods after starting clozapine. Estimated savings were computed according to costs of hospitalization in general hospitals, private psychiatric hospitals, and state hospitals in Massachusetts. It was found that both the mean number of hospitalizations and the mean number of days of hospitalization were significantly smaller in each of the five 6-month follow-up periods than in the 6 months prior to clozapine treatment. We conclude that for some severely ill psychotic patients, clozapine- despite its expense-may significantly reduce the number and length of hospitalizations and, thus, be a cost efficient form of treatment.
No takes yet. Share an insight, caveat, or question.
Frankenburg et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: